IontoPatch is a self-contained iontophoresis patch used to deliver an appropriately selected, electrically charged medication through intact skin. Healthcare professionals commonly consider iontophoresis when they want localized, needle-free medication delivery to a relatively superficial treatment area.
Commonly discussed applications include:
- Lateral elbow tendinopathy, commonly called tennis elbow
- Plantar heel pain or plantar fasciitis
- Patellar tendinopathy, commonly called jumper’s knee
- Achilles tendinopathy
- Selected superficial shoulder conditions
These examples do not mean that IontoPatch is automatically appropriate for every patient with pain in one of these areas. The diagnosis, medication, medication polarity, dose, patch model, placement, skin condition, treatment schedule, and rehabilitation plan must be determined by a qualified healthcare professional. The device itself is broadly intended to administer soluble ionic compounds for medical purposes rather than being labeled as a cure for one particular diagnosis.
Compare the current IontoPATCH STAT, IontoPATCH 80, and IontoPatch Extra Strength models, or read How the IontoPatch Works for an explanation of medication polarity and transdermal delivery.
Common IontoPatch Uses at a Glance
| Condition or treatment area | Why iontophoresis may be considered | Evidence context |
|---|---|---|
| Lateral elbow tendinopathy | Localized treatment area near the skin; may accompany grip-strength and loading rehabilitation | Direct randomized research involving a self-contained IontoPatch |
| Plantar fasciitis or plantar heel pain | Medication may be directed toward a focal heel or plantar-fascia region | Broader iontophoresis evidence; generally considered a second-line adjunct |
| Patellar tendinopathy | Superficial tendon region below the kneecap; wearable treatment may fit an athletic workflow | Randomized wireless-patch evidence, but not specifically with the current IontoPatch family |
| Achilles tendinopathy | Superficial tendon location may permit localized application | Some condition-specific evidence, but results and recommendations have evolved |
| Selected shoulder conditions | May be considered for a superficial, clinician-identified treatment site | Evidence is limited and mixed, particularly for calcific rotator-cuff conditions |
| Other superficial soft-tissue areas | May be considered when the medication, polarity, anatomy, and clinical objective are suitable | Evidence must be evaluated for the particular condition and protocol |
The strength of evidence is not equal across these uses. The strongest direct IontoPatch clinical study concerns lateral epicondylitis. Research involving the foot, knee, Achilles tendon, and shoulder more often evaluates iontophoresis generally or another wired or wireless delivery system.
How IontoPatch Delivers Medication
Iontophoresis uses a low-level direct current to help move charged medication molecules through intact skin. The medication is placed in the chamber having the same polarity:
- A negatively charged medication is placed in the negative chamber.
- A positively charged medication is placed in the positive chamber.
- The opposite chamber is prepared with the activation solution specified in the instructions.
- When both chambers contact the skin, the electrical circuit is completed and delivery begins.
The process is often summarized as “like charges repel.” The electrical field pushes the charged medication away from the similarly charged chamber and toward the skin. Iontophoresis dose is expressed in milliamp-minutes, or mA·min:
Dose = current in milliamps × treatment time in minutes
IontoPatch distributes that dose at a low current over several hours rather than using a separate controller and external wires.
For technical information, see our IontoPatch Principles of Operation.
Important Medication Note
IontoPatch is not supplied with medication. The prescribing clinician is responsible for determining:
- Which medication or ionic solution is appropriate
- Whether the formulation can be delivered through iontophoresis
- The medication’s electrical polarity
- The treatment dose
- Which patch model should be used
- Where the medicated chamber should be placed
- How long the patient should wear the patch
- How the treatment fits into the overall rehabilitation plan
A diagnosis alone does not determine the correct medication or patch.
1. IontoPatch for Lateral Elbow Tendinopathy
Lateral elbow tendinopathy, often called tennis elbow or lateral epicondylitis, commonly produces pain near the outside of the elbow during gripping, lifting, wrist extension, tool use, or repetitive hand activity.
This is the application with the strongest direct research involving a self-contained IontoPatch.
A prospective randomized study compared:
- Dexamethasone delivered through a self-contained iontophoresis patch
- A dexamethasone injection
- A triamcinolone injection
All participants also completed the same hand-therapy program. The patch group experienced better short-term grip strength and unrestricted return-to-work outcomes on selected measures. Pain and function improved among the treatment groups, and the groups had equivalent measured outcomes at six months.
What the Tennis-Elbow Study Means
| Supported interpretation | Unsupported interpretation |
|---|---|
| A self-contained dexamethasone iontophoresis patch produced selected short-term benefits in the study | IontoPatch permanently cures tennis elbow |
| The patch may be considered as one treatment option | The patch is always better than an injection |
| Medication delivery was combined with structured hand therapy | The patch replaces strengthening and activity modification |
| Grip strength and work status improved earlier in the patch group | Every patient will experience the same result |
| Outcomes were similar among groups at six months | The study proved long-term superiority |
The trial evaluated an earlier self-contained patch protocol and should not be described as a direct clinical trial of every current IontoPATCH STAT, 80, or Extra Strength configuration. Review our expanded IontoPatch clinical research summary for study design, outcomes, and limitations.
How It May Fit Into Rehabilitation
When clinically appropriate, iontophoresis may be combined with:
- Temporary modification of aggravating gripping or lifting activities
- Progressive wrist and forearm loading
- Grip-strength rehabilitation
- Shoulder and upper-extremity strengthening
- Ergonomic modification
- A gradual return-to-work or return-to-sport plan
The medication-delivery treatment should not be presented as a substitute for the mechanical-loading and functional portions of rehabilitation.
2. IontoPatch for Plantar Fasciitis and Plantar Heel Pain
Plantar fasciitis commonly causes pain near the bottom of the heel, often during the first steps after rest or after extended weight-bearing. Because the symptomatic region is relatively superficial, clinicians sometimes consider iontophoresis as an adjunct when localized medication delivery is appropriate.
The evidence is broader than IontoPatch alone. Studies have evaluated iontophoresis using dexamethasone, acetic acid or acetate formulations, lidocaine combinations, saline controls, and taping programs.
A 2025 systematic review found moderate evidence that iontophoresis and Low-Dye taping were associated with reduced plantar-fasciitis pain, particularly in the short term. The authors also noted substantial differences among study medications, protocols, sample sizes, and follow-up periods.
The 2023 clinical practice guideline for plantar heel pain recommends manual therapy, stretching, appropriate orthoses, taping, and other rehabilitation measures ahead of electrotherapeutic modalities for broader short- and long-term improvement. It states that iontophoresis may be considered a second-line treatment.
Plantar-Fasciitis Treatment Comparison
| Treatment component | Primary role | Evidence positioning |
|---|---|---|
| Plantar-fascia and calf stretching | Addresses mobility and tissue-loading factors | Common foundational intervention |
| Manual therapy | Addresses relevant joint and soft-tissue restrictions | Recommended in current physical-therapy guidance |
| Taping | Provides temporary mechanical support | Useful for short-term symptom management |
| Foot orthoses | Helps modify loading when combined with other care | Generally not recommended as the only treatment |
| Progressive strengthening | Improves foot and lower-leg capacity | Important rehabilitation component |
| Iontophoresis | Delivers prescribed ionic medication locally | Potential second-line adjunct |
| Injection | Delivers medication with a needle | Separate intervention with its own risks and indications |
IontoPatch is one possible addition to a plantar-heel rehabilitation plan—not as a replacement for stretching, strengthening, footwear management, taping, or evaluation of contributing load factors.
3. IontoPatch for Patellar Tendinopathy
Patellar tendinopathy, often called jumper’s knee, typically produces pain near the tendon connecting the kneecap to the shinbone. Symptoms are commonly aggravated by jumping, landing, squatting, stairs, running, or other high-load knee activity.
A randomized trial compared:
- Dexamethasone delivered through a wireless iontophoresis patch
- Dexamethasone delivered with a wired iontophoresis controller
- Sham treatment
All groups improved, but the two active iontophoresis groups produced greater pain reduction during a functional task. The wireless and wired delivery methods produced similar measured outcomes. The study involved a different wireless-patch system, not the current IontoPatch product family, so it supports wearable iontophoresis as a category rather than directly validating a specific IontoPatch model.
Patellar-Tendinopathy Treatment Priorities
| Treatment approach | Typical role |
|---|---|
| Load modification | Temporarily reduces aggravating jumping, sprinting, or repeated knee loading |
| Isometric or progressive resistance exercise | Develops tendon and quadriceps load tolerance |
| Eccentric or heavy-slow resistance training | Commonly used as part of progressive tendon rehabilitation |
| Sport-specific progression | Restores jumping, landing, running, and change-of-direction capacity |
| Iontophoresis | May be considered for clinician-directed localized medication delivery |
| Passive rest alone | May reduce symptoms temporarily but does not rebuild tissue capacity |
Systematic reviews note that exercise-based loading remains a central treatment for patellar tendinopathy and that evidence for many additional interventions remains conflicting.
4. IontoPatch for Achilles Tendinopathy
Achilles tendinopathy commonly causes pain, stiffness, and reduced load tolerance in the tendon connecting the calf muscles to the heel. Because the Achilles tendon is close to the skin, it is sometimes considered anatomically accessible for iontophoresis.
Earlier clinical guidance recommended considering dexamethasone iontophoresis to reduce pain and improve function in patients with Achilles tendon symptoms.
The evidence should nevertheless be described cautiously:
- Studies use different definitions of acute, midportion, and insertional Achilles tendinopathy.
- Protocols differ in medication, dose, number of treatments, and delivery system.
- Current Achilles guidance emphasizes education and progressive tendon-loading exercise.
- The 2024 midportion Achilles guideline excluded pharmacological interventions from its scope, so it does not provide an updated recommendation for or against dexamethasone iontophoresis.
Achilles-Tendinopathy Care Comparison
| Approach | What it addresses |
|---|---|
| Activity and load modification | Controls aggravating running, jumping, or climbing loads |
| Progressive calf strengthening | Restores tendon and calf-muscle capacity |
| Heel lifts when appropriate | Temporarily reduces ankle motion and tendon strain |
| Mobility work | Addresses relevant ankle restrictions |
| Iontophoresis | Delivers prescribed medication to a superficial treatment site |
| Return-to-running progression | Gradually restores sport-specific loading |
5. IontoPatch for Rotator-Cuff and Shoulder Conditions
The manufacturer lists rotator-cuff tendinitis among commonly discussed IontoPatch applications. However, “shoulder pain” can arise from many different conditions, including rotator-cuff tendinopathy, bursitis, partial tears, osteoarthritis, referred pain, adhesive capsulitis, and calcific tendinopathy. A diagnosis should be established before selecting a treatment.
Evidence concerning iontophoresis for shoulder conditions is more limited and mixed than the direct lateral-elbow evidence.
Research on calcific rotator-cuff tendinopathy has often evaluated acetic-acid iontophoresis, sometimes combined with ultrasound or physiotherapy. One randomized trial found that acetic-acid iontophoresis plus physiotherapy did not produce better clinical or radiographic results than physiotherapy alone. Individual case reports have described improvement, but case reports cannot establish general effectiveness.
Shoulder Evidence Requires Extra Precision
| Claim | Appropriate? |
|---|---|
| Iontophoresis has been studied for selected superficial shoulder conditions | Yes |
| The evidence for calcific rotator-cuff tendinopathy is mixed | Yes |
| IontoPatch is proven to treat all forms of shoulder pain | No |
| Rotator-cuff exercise and rehabilitation may still be required | Yes |
| A clinician must identify the specific shoulder diagnosis and treatment site | Yes |
| Acetic acid and an ionic acetate salt are automatically interchangeable | No |
The IontoPatch technical overview warns that non-ionic compounds are not delivered effectively merely because a related ionic compound exists. Medication formulation and polarity must be confirmed by the prescriber.
Direct IontoPatch Evidence vs. General Iontophoresis Evidence
| Evidence category | Example | What can reasonably be said |
|---|---|---|
| Direct IontoPatch research | Self-contained patch study for lateral epicondylitis | Direct evidence supports selected short-term outcomes under the tested protocol |
| Wireless-patch research | Patellar-tendinopathy trial using another patch system | Supports wearable iontophoresis generally, not a specific IontoPatch model |
| Wired-controller research | Clinical treatment using a separate dose controller and electrodes | Supports iontophoresis as a modality, but not necessarily wearable-patch performance |
| Clinical practice guideline | Plantar-heel or Achilles guidance | Helps position iontophoresis within broader rehabilitation |
| Laboratory medication-delivery study | Skin or tissue penetration research | Supports the delivery mechanism, not clinical effectiveness |
| Manufacturer common-use example | Elbow, foot, knee, Achilles or shoulder | Identifies common clinical positioning, not guaranteed treatment success |
Which IontoPatch Model Is Used for Each Condition?
The model should not be chosen by diagnosis alone. STAT, 80, and Extra Strength differ primarily in dose capacity, delivery profile, average wear time, active area, and fill volume.
| Feature | IontoPATCH STAT | IontoPATCH 80 | IontoPatch Extra Strength |
|---|---|---|---|
| Dose capacity | 80 mA·min | 80 mA·min | 120 mA·min |
| Average wear time | About 4 hours | About 14 hours | About 8 hours |
| Fill volume | 1.0 mL | 1.3 mL | 1.0 mL |
| Primary distinction | Shortest current IontoPatch treatment window | Lower-current, extended-wear format | Higher labeled electrical dose |
| Typical scheduling fit | Daytime or shorter treatment window | Workday, extended wear, or comfort-focused delivery | Higher-dose clinician-directed protocol |
| Medication included | No | No | No |
| External controller required | No | No | No |
Why Diagnosis Alone Is Not Enough
A clinician may choose different patches for two patients with the same diagnosis because of differences in:
- Prescribed dose
- Medication volume
- Skin sensitivity
- Treatment-site size
- Adhesion requirements
- Work or activity schedule
- Previous response to iontophoresis
- Desired delivery rate
- Treatment frequency
Extra Strength is not automatically “better” for a more painful condition, and STAT is not automatically better because it delivers its dose faster. Model selection should match the prescription and patient-specific plan.
IontoPatch vs. Other Iontophoresis Systems
We offer wearable patches and traditional controller-based systems. The underlying objective is localized ion delivery, but the workflow differs.
| Feature | IontoPatch | ACTIVApatch | ActivaDose II |
|---|---|---|---|
| System type | Disposable wearable patch | Disposable wearable patch | Reusable wired controller |
| External wires | No | No | Yes |
| Dose options | 80 or 120 mA·min, depending on model | 40 or 80 mA·min, depending on model | Adjustable from 0–80 mA·min |
| Treatment time | About 4, 8, or 14 hours | About 1.25, 2.5, 4, or 12 hours | Calculated from selected dose and current |
| Current control during treatment | Preset by patch design | Preset by patch design | Clinician-adjustable |
| Medication included | No | No | No |
| Saline or activation solution | Used according to IontoPatch instructions | Current ACTIVApatch options do not require saline | Depends on the selected electrode kit |
| Patient mobility | High | High | Limited while connected |
| Real-time display | No | LED feedback on IntelliDose 2.5 | Dose, current time, and alert display |
| Common workflow | Apply in clinic and wear during instructed activity | Fast or extended wearable treatment | Supervised clinic treatment with direct current control |
Browse our complete iontophoresis patch, electrode, and dose-controller collection to compare these systems.
When Might a Wearable Patch Be Preferred?
A clinician may prefer a wearable IontoPatch when:
- The patient cannot remain connected to a clinic controller for the full treatment
- Mobility during the treatment window is desirable
- A self-contained, wire-free setup fits the workflow
- A 4-, 8-, or 14-hour average delivery window is appropriate
- The prescribed dose is available in the selected model
- The treatment area can maintain reliable skin contact
- The patient can follow removal and skin-monitoring instructions
A reusable controller may be preferred when:
- The clinician wants direct control over current and dose
- The patient should be monitored throughout the treatment
- The current may need to be adjusted during delivery
- A shorter supervised session is more appropriate
- The clinic already maintains compatible electrodes and lead wires
- The treatment site is difficult to manage with a wearable patch
Where Can IontoPatch Be Placed?
The medicated chamber should be positioned over the clinician-identified treatment site. Commonly discussed anatomical regions include:
| Region | Practical placement consideration |
|---|---|
| Lateral elbow | Allow enough movement for elbow and wrist activity without pulling the adhesive |
| Plantar heel | Avoid placement that is repeatedly crushed or rubbed by footwear |
| Patellar tendon | Consider knee bending, clothing, braces, and athletic activity |
| Achilles tendon | Avoid excessive pressure from the heel counter of a shoe |
| Shoulder | Confirm that the patch follows the contour and is not displaced by clothing |
| Wrist or hand | Expect frequent movement and potential edge lifting |
| Ankle or foot | Consider shoes, socks, braces, and weight-bearing friction |
Apply the patch to clean, dry, intact skin and follow the prescribed location. Do not move the medicated chamber simply to make the patch more convenient to wear.
Patients who will remain active should review Using IontoPatch During Exercise.
When IontoPatch May Not Be Appropriate
IontoPatch should not be assumed appropriate when:
- The medication or formulation is not suitable for iontophoresis
- The medication polarity is unknown
- The treatment target is too deep for a superficial delivery approach
- The skin is damaged, denuded, infected, or significantly irritated
- The patient has a known allergy or sensitivity to the medication
- The proposed location is around the orbital region
- The patch cannot maintain reliable contact
- A brace or garment would create excessive pressure
- The patient cannot follow wear, removal, or monitoring instructions
- The treatment would occur during MRI
- The diagnosis has not been adequately evaluated
Do not place it over damaged skin and around the eye region; it warns that medication can cause local or systemic effects and instructs patients to report undue burning or pain. The IontoPatch must be removed before an MRI.
For skin-response guidance, read IontoPatch Discomfort: Irritation, Burning & Removal Guide.
IontoPatch Is Usually an Adjunct—not the Entire Treatment Plan
Many conditions commonly associated with iontophoresis are load-related musculoskeletal disorders. Medication delivery may help manage symptoms, but it does not automatically correct:
- Reduced tendon strength
- Poor load tolerance
- Weakness
- Mobility restrictions
- Training errors
- Occupational overuse
- Footwear problems
- Movement or ergonomic factors
| Clinical objective | Treatment that may address it |
|---|---|
| Deliver prescribed ionic medication locally | IontoPatch or another iontophoresis system |
| Improve tendon capacity | Progressive resistance exercise |
| Restore mobility | Stretching, mobility work or manual therapy |
| Reduce aggravating load | Activity modification |
| Improve support | Taping, bracing, footwear or orthoses when appropriate |
| Restore work or sport function | Graded functional progression |
| Monitor improvement | Condition-specific pain, strength and function measures |
Frequently Asked Questions
What is the most common use for IontoPatch?
IontoPatch is commonly used for clinician-directed delivery of ionic medication to superficial musculoskeletal treatment areas. Manufacturer examples include the lateral elbow, plantar heel, patellar tendon, Achilles tendon, and selected shoulder regions.
Is IontoPatch only used with dexamethasone?
No. Dexamethasone sodium phosphate is frequently discussed in musculoskeletal iontophoresis research, but IontoPatch is a drug-delivery device rather than a prefilled dexamethasone product. The prescribing clinician must determine whether a particular soluble ionic medication and formulation are appropriate.
Does IontoPatch contain medication?
No. Medication is supplied separately and placed in the appropriate chamber at the time of application.
Is IontoPatch used for tennis elbow?
Yes, lateral elbow tendinopathy is one of the most commonly discussed uses. A randomized study directly evaluated a self-contained dexamethasone IontoPatch against two corticosteroid injection protocols and found selected short-term benefits, although measured outcomes were equivalent at six months.
Can IontoPatch be used for plantar fasciitis?
Iontophoresis may be considered as a second-line adjunct for plantar heel pain when directed by a clinician. Current guidance gives greater priority to manual therapy, stretching, taping, strengthening, and appropriate foot-support strategies for broader improvement.
Is IontoPatch proven for patellar tendinopathy?
A randomized study supports wireless iontophoresis for reducing pain during a functional task in patellar tendinopathy, but the trial used another wireless patch rather than a current IontoPatch model.
Can IontoPatch be used over the Achilles tendon?
Achilles tendinopathy is commonly discussed as an iontophoresis application because the tendon is relatively superficial. The evidence and treatment recommendations vary by the type and stage of Achilles disorder, so the patch should be used only as part of a clinician-directed plan.
Does IontoPatch treat rotator-cuff tears?
It should not be marketed as a treatment for all rotator-cuff tears. Shoulder pain requires diagnosis, and evidence concerning iontophoresis for rotator-cuff conditions is limited and mixed.
Can I use IontoPatch for any painful area?
No. Pain location alone is not enough. The medication must be appropriate for iontophoresis, the target area must be suitable, the skin must be intact, and the treatment must be medically directed.
Does IontoPatch replace an injection?
It can provide a needle-free medication-delivery route in selected situations, but it should not be described as a universal replacement for injection. The appropriate route depends on the diagnosis, medication, treatment target, evidence, risks, and prescriber’s judgment.
Can IontoPatch replace oral medication?
Not automatically. Local iontophoresis and systemic medication have different purposes, delivery patterns, risks, and clinical indications. Patients should not stop or replace prescribed medication unless directed by the prescriber.
Can I exercise while wearing IontoPatch?
The wearable patch can accommodate normal activity when the exercise and treatment location are appropriate. Avoid friction, water immersion, tight wrapping, or excessive pressure. See our IontoPatch exercise and activity guide.
What should I do if the patch burns or hurts?
Remove it slowly with soap and water, clean and inspect the skin, and contact the healthcare provider. Significant burning, sharp pain, blistering, or a worsening reaction should not be ignored.
Which IontoPatch model is best for tendon pain?
There is no single model that is best for every tendon condition. STAT, 80, and Extra Strength differ by dose, delivery profile, fill volume, and average wear time. The clinician should select the model that matches the prescribed protocol.
Evidence-Based Conclusion
IontoPatch is most commonly used for localized, clinician-directed delivery of ionic medication to superficial musculoskeletal treatment areas. Manufacturer examples include lateral elbow tendinopathy, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and selected rotator-cuff or shoulder conditions.
The evidence is strongest and most direct for lateral epicondylitis, where a randomized IontoPatch study reported selected short-term benefits. Plantar-fasciitis evidence supports iontophoresis primarily as a short-term or second-line adjunct. Wireless-patch research for patellar tendinopathy is encouraging but did not evaluate the current IontoPatch family. Evidence for Achilles and shoulder conditions is more limited, protocol-dependent, or mixed.
IontoPatch is a wearable drug-delivery tool that may support a broader rehabilitation plan. It should not be promoted as a universal pain patch, a stand-alone tendon cure, or an automatic substitute for injections, oral medication, exercise, or professional evaluation.
Explore:
- IontoPATCH STAT, IontoPATCH 80, and IontoPatch Extra Strength
- IontoPatch Evidence-Based Research
- How the IontoPatch Works
- IontoPatch Technical Overview
- Using IontoPatch During Exercise
- IontoPatch Discomfort and Removal Guide
- Iontophoresis Patches, Electrodes and Dose Controllers
Medical and Professional-Use Notice
IontoPatch is intended for clinician-directed iontophoresis drug-delivery applications. Diagnosis, medication, formulation, concentration, polarity, dose, treatment location, patch model, wear time, treatment frequency, and rehabilitation plan should be determined by an appropriately licensed healthcare professional.
This article provides general product education. It does not recommend a medication, diagnose a condition, establish medical necessity, or replace the manufacturer’s instructions, medication labeling, or individualized medical care.
